Prism Clinical Imaging® delivers clinical value you can see. Prism provides physicians with breakthrough imaging tools to plan and treat brain tumors and other neurological disorders. Images acquired from multiple modalities are registered and presented in “decks” for clinical interpretation. Prism integrates anatomical, functional and physiological images for practical use in the general clinical workflow.
The result: fast, accurate treatment planning, safer treatment delivery and improved quality of life for the nation’s 360,000 brain cancer patients.
Prism Clinical Imaging® products are FDA-approved.
Prism Acquire® is an advanced medical software tool that assists technologists in the acquisition of functional and physiological images.
Prism View® provides a powerful, intuitive physician interface for the interpretation of multimodality, multiparameter imaging studies.
News and Events
57th Annual Meeting, ASNR
The American Society of Neuroradiology will convene in Boston, Massachusetts. Prism will be there with the latest developments in brain mapping.
Benefits of presurgical brain mapping highlighted
Several recent papers describe techniques for using fMRI and DTI/tractography to improve surgical outcomes.
Prism Version 4.1
The latest release of the FDA-cleared suite of clinical tools for pre-treatment brain mapping is now available.
Increase Clinical Productivity.
Physicians report that our products shorten complex, multi-hour procedures to less than two hours.
Prism products improve patient safety and physician productivity.